Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amantadine and Aspirin for fatigue in multiple sclerosis
IRCT201112208430N3Phase 2Completed
- Sponsor
- Neuroscience Research Center, Kerman University of Medical Sciences
- Start
- Jun 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of amantadine and aspirin in multiple sclerosis (MS), sponsored by Neuroscience Research Center, Kerman University of Medical Sciences. Started Jun 2008; status: completed.
02
Drugs
amantadineaspirin
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on IRCT201112208430N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201112208430N3.